Health TrialsbyHealthPanel

Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

ConditionSpinal Dural Arteriovenous Fistula
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThomas Jefferson University

About this trial

Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Type 1 spinal dural arteriovenous fistula, confirmed on imaging

Surgically or endovascularly treated

At least 1 available primary outcome

Disqualifiers

None

Trial population

The registry will include patients from 40 different hospitals in 20 different countries.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Treatment success

Complete surgical/endovascular obliteration of the fistula

Time frame
Recorded at the end of the embolization or surgery.
2

Recurrence

Fistula recurrence

Time frame
Time-to-event Outcome Measures. Estimated period of time over which the event is assessed: on average 1.5 years after surgery.
3

Status of symptoms at last clinical follow-up

Improved, unchanged, or worsened pain, sensory, and motor symptoms

Time frame
Time-to-event Outcome Measures. Estimated period of time over which the event is assessed: on average 1.5 years after surgery.
4

Modified Aminoff-Logue Scale

Gait and bowel/bladder score

Time frame
Time-to-event Outcome Measures. Estimated period of time over which the event is assessed: on average 1.5 years after surgery.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Thomas Jefferson University

Lead sponsor

Source ClinicalTrials.gov
Apply now